These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 7884395)

  • 1. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine in severe head injury.
    Kumar S
    Neurol India; 2004 Sep; 52(3):392-3. PubMed ID: 15472440
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of nimodipine in severe diffuse head injury.
    Nandigam K
    Neurol India; 2004 Sep; 52(3):393. PubMed ID: 15472443
    [No Abstract]   [Full Text] [Related]  

  • 6. Nimodipine in subarachnoid hemorrhage.
    DiPalma JR
    Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral nimodipine and cerebral ischaemia following subarachnoid haemorrhage.
    Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
    Br J Clin Pract; 1990 Feb; 44(2):66-7. PubMed ID: 2200492
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists in the management of subarachnoid haemorrhage.
    Robinson MJ; Teasdale GM
    Cerebrovasc Brain Metab Rev; 1990; 2(3):205-26. PubMed ID: 2223432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
    Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
    Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
    Welty TE
    Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage.
    Tettenborn D; Porto L; Ryman T; Strugo V; Taquoi G; Battye R
    Neurosurg Rev; 1987; 10(2):77-84. PubMed ID: 3329302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic therapy: promising clinical investigations.
    Marshall LF; Marshall SB
    New Horiz; 1995 Aug; 3(3):573-80. PubMed ID: 7496769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
    Brown G; Carley S
    Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine for delayed cerebral ischaemia after subarachnoid haemorrhage.
    Drug Ther Bull; 1992 Oct; 30(21):81-3. PubMed ID: 1425221
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders.
    Sabbatini M; Strocchi P; Amenta F
    Clin Exp Hypertens; 1995 Jul; 17(5):719-50. PubMed ID: 7655445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
    Sakowitz OW; Unterberg AW
    Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Sood AK; Dua A; Mahajan A; Arora S
    J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.